Please assess the completion status of the following clinical trial:

Trial Title: Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Main inclusion Criteria:~* Must have pathologic documentation of non-small cell lung cancer, IB, II, IIIA.~* ECOG Performance Status of 0 - 1~* Bidimensionally measurable disease or evaluable disease~* Adequate organ function~Main exclusion Criteria:~* Have greater than Grade 1 neuropathy - motor/sensory~* Significant history of cardiac disease~* Pleural effusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: OTHER): None
- B (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).